Analyst Ratings For Seattle Genetics (NASDAQ:SGEN)
Today, Cowen and Company reiterated its Hold rating on Seattle Genetics (NASDAQ:SGEN) with a price target of $54.00.
There are 3 sell ratings, 9 hold ratings, 7 buy ratings on the stock.
The current consensus rating on Seattle Genetics (NASDAQ:SGEN) is Hold (Score: 2.21) with a consensus target price of $61.62 per share, a potential 16.32% upside.
Some recent analyst ratings include
- 7/28/2017-Cowen and Company Reiterated Rating of Hold.
- 7/27/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 6/26/2017-William Blair Reiterated Rating of Outperform.
- 6/27/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
- 6/27/2017-Piper Jaffray Companies Reiterated Rating of Neutral.
- 6/26/2017-Cantor Fitzgerald Reiterated Rating of Hold.
- 6/23/2017-Barclays PLC Reiterated Rating of Hold.
Recent Insider Trading Activity For Seattle Genetics (NASDAQ:SGEN)
Seattle Genetics (NASDAQ:SGEN) has insider ownership of 33.30% and institutional ownership of 98.04%.
- On 7/5/2017 Clay B. Siegall, CEO, sold 10,423 with an average share price of $51.98 per share and the total transaction amounting to $541,787.54. View SEC Filing
- On 6/22/2017 Jonathan G Drachman, CMO, sold 10,000 with an average share price of $64.01 per share and the total transaction amounting to $640,100.00. View SEC Filing
- On 6/5/2017 Clay B. Siegall, Insider, sold 10,423 with an average share price of $65.21 per share and the total transaction amounting to $679,683.83. View SEC Filing
- On 4/5/2017 Clay B Siegall, Insider, sold 14,465 with an average share price of $62.99 per share and the total transaction amounting to $911,150.35. View SEC Filing
- On 3/31/2017 Vaughn B Himes, Insider, sold 10,000 with an average share price of $62.75 per share and the total transaction amounting to $627,500.00. View SEC Filing
- On 3/6/2017 Clay B Siegall, CEO, sold 14,465 with an average share price of $68.04 per share and the total transaction amounting to $984,198.60. View SEC Filing
- On 2/6/2017 Clay B Siegall, Insider, sold 14,465 with an average share price of $61.54 per share and the total transaction amounting to $890,176.10. View SEC Filing
Recent Trading Activity for Seattle Genetics (NASDAQ:SGEN)
Shares of Seattle Genetics closed the previous trading session at 52.97 down -2.05 -3.73% with 1,178,514 shares trading hands.